Background: The use of functionalized graphene oxide (fGO) has led to a new trend in the sensor field, owing to its high sensitivity with regards to sensing characteristics and easy synthesis procedures. Methods: In this study, we developed an ultra-sensitive carboxyl-graphene oxide (carboxyl-GO)-based surface plasmon resonance (SPR) aptasensor using peptides to detect human chorionic gonadotropin (hCG) in clinical serum samples. The carboxyl-GO based SPR aptasensor provided high affinity and stronger binding of peptides, which are great importance to allow for a non-immunological label-free mechanism. Also, it allows the detection of low concentrations of hCG, which are in turn considered to be important clinical parameters to diagnose ectopic pregnancies and paraneoplastic syndromes. Results: The high selectivity of the carboxyl-GO-based SPR aptasensor for hCG recombinant protein was verified by the addition of the interfering proteins bovine serum albumin (BSA) and human serum albumin (HSA), which did not affect the sensitivity of the sensor. The carboxyl-GO-based chip can enhance the assay efficacy of interactions between peptides and had a high affinity binding for a k a of 17×10 6 M −1 S −1
Introduction
Graphene is an advanced two-dimensional (2D) layered material with unique and excellent mechanical, electrical and optical properties such as high tensile strength, 1, 2 high conductivity, 2, 3 and high transmittance. 4 Its structure on the atomic-scale is a hexagonal allotrope of carbon. In addition, it has the same properties as the derivatives of graphene-based materials such as graphene oxide (GO) and reduced graphene oxide (rGO) sheets. Controlling the oxygen content in the oxygen functional groups on the surface of GO sheets can improve biological affinity, [5] [6] [7] modulate plasmonics, 8 change material with almost unlimited potential which can be inexpensively produced. It has been extensively studied and successfully used in the development of biosensor, 5, [11] [12] [13] and optoelectronic devices. 8 The structure and functionalization properties of GO with regards to peptides has gained increasing interest with regards to its use as a biosensor. Owing to the ability of GO sheets to specifically bind to a given target biomolecule, they allow for a new experimental strategy for functional peptide analysis. In addition, the application of GO-based biosensor technology in biological sensing devices has rapidly increased in a wide variety of diagnostic fields including genetic diseases and cancer, in order to identify proteomes and new drugs. Our previous study successfully demonstrated the interactions between GO and proteins, 5 the development of GO for immunoassays, 13 and the determination of GO-peptide interactions. 14 Compared with a conventional bare Au-based SPR chip, the GO-based SPR chip had ultrahigh sensitivity to detect biomolecules. In addition to the development of highly sensitive measurement techniques, we also successfully developed carboxyl-GO for use in an immunoassay biosensor. 15 Most of the reported surface plasmon resonance (SPR)-based biosensors have used graphene, 16, 17 reduced GO, 18, 19 graphene-decorated metal nanoparticles, 13, 20 or MoS 2 -COOH as the sensing film chip. 21 Moreover, novel strategies for the synthesis of surface functionalized graphene oxide (fGO) sheets have used a modification/doping process to improve the electronic carrier properties via oxidizing (p-doping) or reducing (n-doping) enhanced charge trapping at the interfaces, 22 or regulating the energy gap shift to a visible light wavelength 23 or enhancing the excellent photocatalytic features for bio-sensing applications. 24, 25 In addition, more effective modification of the fGO sheets can be achieved on vicinal surfaces, selected using colloid chemistry or chemical compound methods with functional molecules, and also synthesized via self-assembly of organic molecules to enhance the highly sensitive detection. The most promising aptamer peptide-based biosensors are currently aptasensors, due to advantages such as cheap production, high purity, resistance to high temperatures and easy synthesis. In addition, the high selectivity and specificity of peptide binding to a protein represents a significant challenge for molecular diagnosis applications, which can be achieved by immobilization on a sensor surface with the correct orientation. 26 Therefore, the application of molecular detection technology has been widely studied. Other peptide-based SPR biosensors have been used to detect heavy metals, 27, 28 the real-time detection of breast cancer, 29 staphylococcal enterotoxin B, 30 and peptide-Au nanorods to detect cardiac biomarkers. 31 In addition, the peptidegraphene based combination has uniquely excellent properties for use in non-immunological biosensors, 32, 33 antimicrobial, 34 and drug carriers. 35 These techniques are currently limited to standard recombinant protein tests, and they have not yet been tested in clinical sera for diagnostic studies. As a clinical molecular diagnostic tool, an SPRpeptide based biosensor appears to be a very promising diagnostic technology. However, few SPR-peptide biosensors have been developed as clinical blood diagnostic tools, especially to detect relevant disease biomarker proteins in the blood of pregnant women. Of these biomarkers, human chorionic gonadotropin (hCG) is a very important protein which can be used to detect pregnancy and related morbidities such as ectopic pregnancy, 36 miscarriage, 37 fetal abnormalities, 38 and testicular tumors. 39 Therefore, the development of a highly sensitive and rapid detection diagnostic chip to estimate the amount of hCG protein is necessary. The hCG protein is a hormone essential for the maintenance of pregnancy and the development of both placenta and fetus. Therefore, the development of an SPR biosensor for hCG determination in blood is a very significant task. Recently, a few peptide aptamer based biosensors have been found and used as the recognition elements for binding to hCG proteins. For example, Ding et al reported a LC-based immunoassay method to detect hCG, a limit of detection (LOD) is approximately 1 IU/mL (2 nM). 40 Chang et al reported a colorimetric detection of hCG-binding peptide aptamer and utilized this in catalytic gold nanoparticles (Au NPs)-based assay, a LOD of 15 mIU/mL (1.5 ng/mL) can be achieved. 41 Xia et al reported silver nanoparticles (Ag NPs)-based colorimetric assay method to detect hCG, a LOD of 0.4 mIU/mL was achieved. 42 In our previous study, we reported a graphene oxide (GO) SPR biosensor based on a peptide aptamer for hCG assay with a detection limit of 0.065 nM (3.25 ng/mL, 32.5 mIU/mL). 14 The detection limit of hCG serum test in quantitative ELISA is 0.5 ng/mL (5.0 mIU/mL). To date, no peptidebased or graphene-based SPR biosensor has been reported for the detection of hCG in clinical blood samples. In this study, we developed an ultra-sensitive SPR aptasensor using a non-labeled and non-immunological method involving functionalized carboxyl-GO modification binding peptide techniques. This sensor was shown to be a sensitive and robust tool for the detection and quantification of low levels of hCG in clinical blood serum samples. The carboxyl-GO composite was shown to have biocompatible surfaces beneficial for the detection of covalently-linked peptides in biosensor technology. The peptide was immobilized on the carboxyl-GO surface of the SPR biosensor and had a highly selective and specific interaction with the hCG protein. We used two types of detection methods with standard samples and clinical samples. There were two aims: First, to detect hCG protein in phosphate-buffered saline (PBS) buffer. Since the hCG in the test sample was diluted with PBS, it was relatively simple to detect. Therefore, there was no interference of other protein molecules in the detection. This experiment did not use bovine serum albumin (BSA) to reduce nonspecific binding. Second, to detect hCG protein in clinical specimens. Because the doped clinical samples contained interfering proteins and other molecules that could have caused electrostatic interference and affect SPR detection, BSA was used in this experiment to reduce non-specific binding in the PBS solution. The selectivity of the SPR aptasensor was evaluated by comparing the sensor responses to BSA and human serum albumin (HSA).
Materials and methods

Preparation of the SPR aptasensor and hCG detection method in PBS buffer samples
Modification of the GO sheets was carried out using chloroacetic acid (ClCH₂CO₂H, Alfa Aesar, Ward Hill, MA, USA), which hydroxyl (-OH), epoxide (-O-), and ester groups into the carboxyl group (-COOH) . 15, 43 The main synthesis steps for the conversion of GO to carboxyl-GO are shown in Figure 1A and B. GO solution at a concentration of 2 mg/mL in a volume of 5 mL was prepared and shaken with ultrasound at 350 W for 1-2 hrs to break the GO sheets into flakes of less than 1 μm. This was followed by the addition of 1.0 g of ClCH₂CO₂H and 1.2 g of sodium hydroxide (NaOH) to the GO aqueous suspension in an orbital shaker (swing type) with shaking for 4 hrs at 60°C. A centrifuge was then used to repeatedly remove the ClCH₂CO₂H and NaOH with deionized water. Finally, deionized water was added to achieve a carboxyl-GO solution concentration of 1 mg/mL. The carboxyl-GObased SPR chip was chemically modified using a 47 nm Au electrode with thiol-and amine-group self-assembled monolayers (SAMs) of cystamine (Cys) (cystamine dihydrochloride 98%, Alfa Aesar, Ward Hill, MA, USA). The Au electrode was immersed in a double-distilled water (ddH 2 O) Cys solution diluted to 10 mM for 24 hrs at room temperature. The Au/Cys chip was then immersed in aqueous carboxyl-GO (1 mg/mL) suspension for 5 hrs followed by thorough rinsing with deionized water to remove unbonded carboxyl-GO, resulting in Au/Cys/carboxyl-GO film. As shown in Figure 1C , the first step of enabling carboxyl-GO biological binding was the activation of the -COOH terminal group for direct conjugation to amine (-NH 2 ) bonds to allow for a better affinity reaction. The carboxyl-GO sheets were activated with a 1:1 mixture of 0.1 M N-hydroxysuccinimide (NHS) and 0.4 M l-ethyl-3-(3-dimethyl aminopropyl) carbodiimide (EDC), followed by the injection of 200 μL of the EDC/ NHS solution to activate the -COOH surface at room temperature at an injection flow rate of 30 μL/minute. To develop a SPR aptasensor for short oligopeptide sequences, 40 we used (N-)PPLRINRHILTR(-C) to assay hCG protein. The structural feature of this unique short oligopeptide sequence allows peptide aptamers to bind with the hCG target protein with strong affinity and high specificity. A 100 µM injection of peptide at a flow rate of 30 μL/minute was first immobilized onto the carboxyl-GO surface in SPR flow channel-1. Furthermore, we used 200 μg/mL of BSA protein to block the Cys linker and did not immobilize the peptide probe in flow channel-2, as shown in Figure 1D . To deactivate the NHS ester-terminated groups on the surface that did not react with the peptide, 1 M ethanolamine (EA) solution dissolved in phosphate-buffered saline (PBS) solution was injected over the sensing film at a 30 μL/minute flow rate followed by blocking. This reduced the negative charge of the sensing film surface and thus decreased the potential for nonspecific binding. Figure 1E shows the interaction of the protein with the peptide using injections of different concentrations to detect 200 μL hCG protein at a flow rate of 30 μL/minute. This was followed by further washing with a 1x working concentration of PBS running buffer at a flow rate of 30 μL/minute. Figure 1F shows that the carboxyl-GO-peptide based SPR sensing system was designed based on double flow channel detection using a 690 laser source, employed to angularly resolve SPR sensing in a BI-SPR 3000 dual-channel instrument (Biosensing Instrument Inc., Tempe, AZ, USA).
Preparation of the carboxyl-GO-based chip in clinical samples detected
In clinical samples experiments, different from the detection in PBS buffer samples, we add a step by using 200 μg/ mL of BSA protein blocking to reduce non-specific binding (NSB). This is an important step when performing SPR clinical samples experiments. 44 In an assay with a serum sample, the addition of BSA and Tween-20 (NO. P9523, Sigma-Aldrich, St. Louis, MO, USA) to the blood serum samples was found to improve hydrophobic interactions with other proteins, and charge interactions of NSB of serum proteins with the sensing surface in each experiment. The running buffer (PBBT buffer) was composed of 1x PBS, 0.05% Tween-20, and 600 µL of BSA protein mix at a concentration of 1 mg/mL in a volume of 100 cc to prevent NSB in the human serum and to prevent the proteins from binding to the carboxyl-GO surface. In all experiments, the injection volume was 200 μL and the flow rate was set at 30 μL/min and regeneration solution was 50 mM of NaOH at pH 12.0. The blood serum samples from normal pregnant women at an average gestational age of about 14 weeks were used in this study. The concentration of hCG protein in these serum samples was obtained using ELISA. hCG is a glycoprotein hormone consisting of two non-covalently bound subunits, with a molecular weight of approximately 36 kDa. All of the blood serum supernatant samples were diluted using PBBT buffer to a achieve a series of samples with different concentrations of hCG to minimize the adverse effects of high viscosity on carboxyl-GO sensing performance. Therefore, the detection of blood serum hCG was carried out in the PBBT running buffer, which was designed in such a way as to remove nonspecifically adsorbed proteins while not disrupting the binding of hCG to peptides immobilized on the sensor surface.
Results
Analysis of chemical bonds and morphology of carboxyl-GO sensing films
The self-assembly of carboxyl-functional groups in aqueous suspension with the assistance of chloroacetic acid was demonstrated to be a powerful method to build the carboxyl-GO architecture. The exact carboxyl transformation procedures were verified with different characterization methods. Figure 2A shows the attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR) spectra of the carboxyl-GO, GO and rGO films at three different chip processing conditions. The properties of the primary carboxyl-GO functional groups including epoxide groups (-O), hydroxyl groups (-OH) and carboxylic acid groups (-COOH) on the surface showed the following characteristic features: C-O-C vibrations in the epoxide groups, including the vibration modes of epoxide ring-opening bonds (at 910 cm ) contents (reductions in the Ar-OH at 3,050-3,800 cm −1 ), confirming the carboxyl-functionalization of GO sheets is successful. Figure 2B shows Raman results of GO and carboxyl-GO. The Raman peaks of GO, showed the D (the arises from breathing mode of κ-point photons of A1g symmetry) peak as the characteristic feature at 1,345 cm −1 and the prominent G (the E2g mode of sp2 carbon atoms) peak as the characteristic feature at 1,610 cm
. The intensity of the prominent D peak (1,345 cm
) was comparable with that of the G peak (1,600 cm
) and their large bandwidths revealed structural defects in carboxyl-GO. This change in the ratio (I D /I G ) of intensities of the D and G bands is attributed to the increase in defect concentration from GO to carboxyl-GO. The relative I D /I G ratio is a measure of the defects present on graphene structure, which means that the sp2 bond is broken, and in turn means more sp3 bonds. The number of sp3/sp2 bonds was obtained from the Raman spectral peak intensity ratio (I D /I G ). Extensive oxidation reduced size of the in-plane sp2 domains. The increased I D /I G ratio in Raman spectra sp2 and sp3 suggests a decrease in the average size of the sp2 domains upon reduction of the exfoliated GO, perhaps indicating that new, more numerous but smaller graphitic domains were created.
11,46
The ratio I D /I G equals the sp3/sp2 bond ratio in the carboxyl-GO. The I D /I G ratio for GO is 1.06, and for carboxyl-GO is 1.51. That of carboxyl-GO has a higher I D /I G owing to the presence of unrepaired defects following the chemical modification involves the -OH, -O-, and ester groups into the carboxyl groups. Figure 2C shows representative scanning electron micrograph (SEM) image of the carboxyl-GO sheets, revealing a granular morphology with small clusters of irregular particles, some of which were in the nanoscale.
Intensity (a.u.) 1000 1500 2000 The carboxyl-functional groups presenting as irregular particles were similar to the organic matrix-mediated biomineralization of mollusk shells on a transmission electron micrograph (TEM) image as shown in Figure 2D . 47 X-ray photoelectron spectroscopy analysis of carboxyl-GO sensing films
The carboxyl-GO biocompatible composites were synthesized using the modified Hummer method and then alkylated using chloroacetic acid under basic conditions. Figure 3 shows the presence of carbon and oxygen elemental and chemical state analyses in the carboxyl-GO film using X-ray photoelectron spectroscopy (XPS). Figure 3A shows the XPS spectrum of carboxyl-GO including various nitrogen and oxygen peaks and a carbon peak in the three different sensor chips for Au/ Cys/carboxyl-GO/peptide, Au/Cys/carboxyl-GO, and Au/ Cys/peptide, respectively. Figure 3A shows the survey, carbon of C 1s (285 ev), nitrogen of N 1s (400 ev), and oxygen of O 1s (532 ev) peaks in the XPS spectra of the chips, respectively. Along with the C, N and O peaks, the spectra contained sulfur S 2s (238 ev), which was caused by the -SH of the Cys linker. In addition, the contents of O 1s in the Au/Cys/carboxyl-GO/ peptide and Au/Cys/carboxyl-GO chips were particularly high, which was caused by the oxide of carboxyl-GO. The nitrogen (N1s) component was caused by immobilization of the peptide molecule on the carboxyl-GO surface. As shown in Figure 3B , the N 1s region of the XPS patterns of the carboxyl-GO/peptide chip could be fit using deconvolution into two peaks attributed to two different nitrogen-containing groups: C-N (400.8 eV, 85.2%) and C-NH 2 (399.6 eV, 14.8%). However, it was possible to identify amide and amine binding energies at 399.6 eV and 400.8 eV, respectively. This is consistent with previous studies. 48, 49 The XPS spectrum and deconvoluted C1s and O1s spectra are shown in Figure 3C and D. The XPS spectra of C 1s for carboxyl-GO were deconvoluted into five peaks, 283.7, 285.1, 286.0, 287.1 and 288.2 eV, corresponding to the characteristic peaks of C=C (63.8%), C-C (10.8%), C-O (11.6%), C=O (4.2%), O-C=O (9.6%), respectively, and the relative peak area of carbon atoms bonded to carbon in the carboxyl-GO structure. The XPS spectrum for C1s ( Figure 3C and E) shows the different chemical environments of the carbon atoms bonded to carbon in carboxyl-GO and GO structures. The peak (288.2 eV) in the spectrum of O-C=O contents corresponded to 9.6% and 1.5% carboxyl-GO and GO, respectively. This showed that COOH was successfully modified on the GO surface. Figure 3D and F show the O1s XPS spectra for carboxyl-GO and GO, which revealed a significant degree of oxidation as indicated by the numerous oxygen-containing groups; peaks at 531.5, 532.7 and 533.7 eV were assigned to oxygen atoms in C=O, C-O and O-C=O, respectively. Figure 3D results showed that carboxyl-GO contained significant amounts of O-C=O and C-O (19.2% and 60.1%, respectively), signifying that most of the carboxyl modified on the GO surface was arranged in the structure.
Electrochemical and SPR analysis of carboxyl-GO sensing films
To evaluate the electrochemical performance of the asprepared sensing chips, cyclic voltammetry (CV) curves were measured. Figure 4 , with the frequency ranging from 100 mHz to 100 kHz at 5 mV. Quantitative realtime EC-SPR detection was performed in a 2 mL internal sample volume cell using an integrated system including a CHI-604D electrochemical analyzer work station (CH Instruments Inc., Austin, TX, USA) and BI-3000G SPR Instrument (Biosensing Instrument Inc., USA). In the electrochemical experiment, a three-electrode system was used including the modified Au/carboxyl-GO electrode as the working electrode, platinum (Pt) wire as the counter electrode, and Ag/AgCl (saturated KCl) as the reference electrode.
The CV curve revealed a quasi-rectangular shape, indicating that the carboxyl-functional groups had maintained good charge propagation within the film. Among them, the difference between the two peak potentials ΔE p =|E pc -E pa | =59/n mV was of particular interest (where ΔE p is potential separation, E pa is anodic peak potential, and E pc is cathodic peak potential, the case of n electrons). 50, 51 This difference in peak potentials ΔE p mainly resulted from the effects of sensing film revealing the electrochemical reversibility. Figure 4A shows that ΔE P -values at a scan rate of 10 mV/s were 0.08, 0.063, 0.086, and 0.096 for the bare Au, Au/Cys, Au/Cys/carboxyl-GO, and Au/Cys/arboxyl-GO/peptide sensing chips, respectively. Figure 4B shows that ΔE P -values at a scan rate of 50 mV/s were 0.103, 0.09, 0.086, and 0.122 for the bare Au, Au/Cys, Au/Cys/ carboxyl-GO, and Au/Cys/carboxyl-GO/peptide sensing chips, respectively. This result shows that the electron transport rate of the Au/Cys/carboxyl-GO/peptide sensing chip was hindered due to the adsorption of 100 μM of peptides. This result shows that the peptides cause a decrease in current and an increase in the potential difference of ΔE p . Figure 4C shows that the CV curves of the Au/Cys/carboxyl-GO/peptide chip at a 50 mV/s scan rate were also affected by the intrinsic barrier for electron transfer. The corresponding ΔE p -values were 0.096, 0.096, and 0.122 V for 10, 25, and 50 mV/s scan rates, respectively. Figure 4D shows the results of the electrochemical impedance spectroscopy (EIS) analysis recorded for all of the sensing chips at frequencies from 1 Hz to 100 KHz, an initial potential of 0.24 v and 12 points per decade under excitation of the amplitude when the input ac signal was kept at 5 mV in the presence of equimolar 2 mM [Fe(CN)6] 3-/4-. By fitting the semicircular diameters corresponding to the interfacial electron-transfer resistance at Rct for the bare Au, Au/Cys, Au/Cys/GO, Au/Cys/ carboxyl-GO, and Au/Cys/carboxyl-GO/peptide chips, the values were 27.46, 67.97, 1015, 226.57, and 326.45 Ω, respectively.
The experimental results showed that the added modified Cys and GO, or GO-COOH layer by layer on the bare Au electrode, which resulted in the impedance appeared to be larger because the oxide could hinder electron transfer. Compared with Au/Cys/GO electrodes, the results showed that the Rct values of carboxyl-GO film had effectively decreased, and that the -COOH improved the electroactive surface area which contributed to the more conductive pathways for electron transfer. These findings show that carboxyl-GO could be used as a modifier to construct biosensors with improved performance. 13, 14, 52 Surface modification of GO by negatively charged carboxyl-groups to yield carboxyl-GO could further improve aqueous dispersion, increase conductivity and enhance biological affinity, providing reactant sites for conjugation with positively charged peptides, plus further Abbreviations: Au, gold; Cys, cystamine; GO, graphene oxide; EIS, electrochemical impedance spectroscopy; CV, cyclic voltammetry; SPR, surface plasmon resonance.
functionalization sites for covalent bioconjugations to the activated carboxyl group. 52 In addition, improving the optical conductivity and electrical conductivity of graphene effectively enhanced the sensitivity of sensing. 53 These results provide proof that the conductivity of the surface improved performance of the SPR biosensor. 53, 54 Figure 4E and F show the CV scan voltage-based SPR voltammograms of the different sensing chip redox reactions at different potential scan rates. We used carboxyl-GO due to its remarkable environmental chemical stability, and the drastic change in its electrical conductivity upon simple oxidation and reduction. Moreover, redox reactions in peptide molecules are known to cause conformational changes, although these changes are often very small. However, they can be studied using real-time EC-SPR at different scan rates to measure potential and angle shift. Real-time EC-SPR uses the combination of CV and SPR to monitor interactions of carboxyl-GO and peptide aptamers on the surface of bare gold. Specifically, electrochemistry is the analysis of the rate of permeation reaction of electrons on carboxyl-GO and peptide aptamers, while SPR simultaneously monitors the reaction characteristics of the electric double layer of ions of the peptide aptamers in real time. Therefore, In CV-SPR voltammograms of modified sensing film measurements, the potential-induced SPR angle shift (Δθ SPR ) of the sensing surface-electrolyte interface could be controlled, which induced various interesting phenomena. For example, simple double potential (ΔV d ) could induced SPR angle shift (Δθ SPR ) via sensing film changes in the refractive index (Δn), changes in the average adsorbed monolayer thickness (Δd s ), and surface charge density (Δn e ) of the sensing film. Among these factors, the relationship between Δn e and the interface property of Δd s = -C d (ΔV d /e Δn e ), where C d is the double layer capacitance, the CV-SPR signal was proportional to the potential-induced SPR angle shift given by 55, 56 Δθ
where c 1 , c 2 , and c 3 are constants and λ is the wavelength of the incident light. The potential-induced SPR angle shift was mainly caused by differences in the refractive index between the reduced and oxidized forms of the sensing film complex, but it was also affected by the double layer charging effect. The CV-SPR voltammograms are presented in Figure 4E , which shows significant influence on the trend of potentialinduced SPR angle shifts as the double layer proportionality constant between Δθ SPR and ΔV d is known to be determined by the values of C d and Δd s . Figure 4E clearly shows that in the bare Au chip at a scan rate of 25 mV/s, C d and d s were greater than and in the other two sensing chips, thus leading to a large angle shift of SPR. We also analyzed the SPR signals of Au/Cys and Au/Cys/carboxyl-GO chips, and found two phenomena of note. First, the SPR angle shift attributed to the double layer existing large charging effect in the oxidation reaction (from 0.0 to +0.7 V) became even smaller, which was expected due to the decrease in interfacial capacitance. Second, the SPR angle shift associated with the reduction reaction (from +0.7 to 0.0 V) also decreased significantly due to blockade of the reduction reaction by the Cys/carboxyl-GO film. This result is consistent with the EIS in Figure 4D . Figure 4F shows the CV-SPR voltammograms of the Au/Cys/carboxyl-GO/peptide chip at three different scan rates of 10, 25, and 50 mV/s, which showed potentialinduced SPR angle shift at 50 mV/s. When the scan potential was the oxidation reaction, the SPR angle changes were 50.92, 50.57, 32.34 mdeg for the 10, 25, and 50 mV/s scan rates, respectively. When the scan potential was the reduction reaction, the SPR shifts were observed at −34.82, −18.77, and −9.6 mdeg for the 10, 25, and 50 mV/s scan rates, respectively, which was mainly due to the double charging effect described by Equation (1). The potential-induced SPR angle shift was mainly affected by d s and C d of the sensing film.
Analysis of the interaction between carboxyl-GO sensing film and peptide
Comparisons of the SPR angle shift were performed using the peptide aptamer in three different chips as shown in Figure 5A . The SPR sensorgram showed that the injected peptides at a flow rate of 30 μL/min resulted in SPR angle shifts on the three different sensing chips of 20.51, 14.03, and 9.64 mdeg for the Au/Cys/carboxyl-GO, Au/Cys/GO and convention chips, respectively. These results showed that the carboxyl-GO-based SPR chip had a high affinity binding reaction.
We individually injected the peptides at different flow rates to observe the binding reaction with carboxyl-GO affinity interaction kinetic analysis. Figure 5B shows that with injection at a flow rate of 30 μL/minute the SPR equilibrium contact angle (θ eq ) exhibited a large shift of 22.37 mdeg at 300 s. In addition, at flow rates of 60 and 90 μL/minute at 200 s the θeq values were 10.68 and 10.01 mdeg, respectively. The peptide aptamer had strong adhesion at a flow rate of 30 µL/min, at which a maximum response in SPR angle shift was reached. Flow rates of 60 and 90 µL/min resulted in a gradual decrease in the SPR response. The results showed that the carboxyl-GO with peptide aptamer interface reaction rate was not suitable for more than 30 µL/min. The experimental results are consistent with previous studies. 57, 58 From the different flow rates we calculated the binding kinetics. We performed a 1:1 interaction of the SPR biosensor in carboxyl-GO with peptide molecule using the binding Langmuir model. 59 The binding kinetics parameters of the association rate k a , dissociation rate k d , and dissociation constant K D (k d /k a ) for the interaction of carboxyl-GO with peptide aptamer are shown in Figure 5C . At a flow rate of 30 µL/min, the value of K A was 2.81×10 7 M −1 and that of K D was 0.36×10 -7 M, which was in good agreement with the calculated fit. The results showed that these values were comparable to the highest seen for natural biological immunoassay systems. 58 By fitting the binding obtained under analogous conditions, the values of k a were determined to be 32.57, 13.75 and 7.89×10 4 M −1 s −1 for flow rates of 30, 60, and 90 µL/min, respectively. In kinetic analysis of the peptide aptamer bonded on the carboxyl-GO based chip, an injection flow rate of 30 µL/min resulted in a large angle shift, and also a small K D of 0.36×10 -7 M compared to the other flow rates. This may be because the COOH-modified sensor chip caused interaction effects due to high affinity bonding.
Analysis of the carboxyl-GO/peptide assay of hCG protein in PBS buffer
We performed high affinity quantitative analysis for the binding, elution and regeneration kinetics of peptides and hCG protein assay as shown in Figure 6 . The injecting 100 µM of the peptide at a flow rate of 30 μL/minute was immobilized onto the carboxyl-GO surface in both SPR flow channels. All assay experiments were conducted at room temperature using different hCG protein concentrations injected at a volume of 200 μL and a flow rate of 30 μL/minute. Figure 6A shows the SPR sensorgrams for hCG protein at assay concentrations of 2, 10, 20, 40, 80 and 100 pM on peptides immobilized with the carboxyl-GO chip. Figure 6B and C show the SPR sensorgrams of the carboxyl-GO modified sensor chip for responses using 100 μM peptide to detect hCG protein concentrations in a mixture containing interfering proteins of 20 nM BSA and 20 nM HSA. Figure 6C shows the measured SPR angle responses in the linear fitting calibration curve. The carboxyl-GO chip showed a linear plot for hCG concentrations according to the linear regression equation y=1.01+0.6x and a correlation coefficient (R 2 ) of 0.981. The linear regression of the calibration curves was y=3.23+0.5x (R 2 =0.996) for the adding interfering proteins BSA and HSA, where y represents the resonance angle shift, and x is the hCG concentration. There was clearly no significant interaction between the two proteins and the peptide in the mixed protein experiments, demonstrating the excellent selectivity and binding between the hCG protein and the peptide. The carboxyl-GO-peptide-based SPR biosensor with high-performance affinity was developed to characterize the binding and regeneration kinetics of immobilized carboxyl-GOpeptide and affinity assay. The result was more than the previous paper at flow rate of 60 μL/minute to immobilize the peptide (100 µM) at GO films to detect hCG protein as shown a LOD of 8.32 nM.
14 The stability of the resonance angle of the Au/Cys/carboxyl-GO/peptide chip in the buffer to detect the repeated regeneration of hCG protein was within 10%. Figure 6D shows that the binding kinetic constants of association rate constant (k a ) and dissociation rate constant (k d ) of 2 pM hCG on the carboxyl-GO-based SPR chip were 17×10 6 M −1 S −1 and 0.92×10
, respectively. The error bars represent a range of 30% in the data, and at other concentrations were comparable in size to the data symbols. These results showed that the optimal carboxyl-GO chip had high resolution, binding affinity and slope of intensity mode.
Assay of hCG protein in clinical serum samples
The SPR sensorgrams showing the carboxyl-GO-based chip with interactions between specific peptides and clinical samples of hCG protein are shown in Figure 7 . All clinical serum samples were measured using a 200 μL sample volume and a flow rate of 30 μL/minute. Figure  7A shows the SPR sensorgrams of using EDC/NHS to activate the surface and immobilize the peptide probe on the surface. Activation of -COOH and covalent coupling of the peptide probe and the use of BSA blocking to saturate free binding sites on the sensor surfaces or other protein binding surfaces reduced the handling of nonspecific bonds. Deactivation and the use of NaOH to wash away loosely associated peptide and BSA were performed for non-specific bonding treatment. The final response showed the immobilization of the sensing probe on the carboxyl-GO sensor chip in the channel-1 sensing area. In addition, there was no chemical modification in flow channel-2 and no immobilized peptide probe. Figure 7B shows the SPR sensorgram of using a continuous injection of the serum sample to assay human hCG protein.
The SPR detection system was set up with a series of flow channels, and the injected sample flow direction was from channel-1 to channel-2. The PBBT running buffer was prepared by mixing PBS, BSA, and Tween-20. 44 The serum samples of the pregnant women at 14 weeks of gestation were diluted with different concentrations of 1:20 K and 1:8 K. The clinical serum samples were diluted in the PBBT running buffer. After injecting different concentrations of the serum samples of hCG, there were changes in the sensor response resulting in specific binding interactions of the peptide to the hCG protein.
Washing of the non-covalently bound protein with 200 μL of 50 mM NaOH to regenerate the surface removed the serum sample completely and obtained the baseline value. The obtained results showed that channel-2 did not have any significant protein adsorption, and that interference of non-specific proteins did not significantly cause a reaction. The concentration of hCG in the clinical serum samples was 230 nM (8.7 μg/mL) using ELISA. The clinical serum samples diluted to 1:8 K was equivalent to a concentration of 28.7 pM. After clinical serum samples were injected at a flow rate of 30 μL/minute, the sensor response gradually decreased due to spontaneous dissociation and became almost saturated within 500 s. The response curves of hCG protein flow at different dilutions (concentrations of 1.15-28.7 pM) are shown in Figure 7C . The carboxyl-GO films to detect hCG protein at a low flow rate of 30 µL/min as shows a LOD of 1.15 pM (0.575 mIU/ mL). The results were more than the previous paper in a refrigerator at 4°C for 5 hrs to immobilize the peptide (1 mM) at GO films to detect hCG protein at a high flow rate of 60 µL/min as shown a LOD of 0.065 nM.
14 However, the response curve for a dilution of 1:200 K serum sample flow was clearly different from other dilutions, indicating that dissociation was promoted by hCG protein at a concentration with a limit of detection of 1:200 K (1.15 pM).
The result plotted as response (angle shift versus dilution of hCG serum sample, from the data recorded in Figure 7C ) of the carboxyl-GO SPR aptasensor for the detection of hCG in the serum sample is depicted in Figure 7D . The SPR signal changed linearly with the linearity of the hCG protein concentration. The linear regression equations of the calibration curve were used to fit these data. The solid lines represent linear fits given by the equations, and were determined using data from all three experiments. When the dilution concentration of the clinical serum samples was between 1:8 K to 1:200 K, the linear regression equation was y =1.72 +1.27x, and the correlation coefficient was 0.98.
Comparing Figure 6C versus Figure 7D (calibration with standard solutions in buffer versus calibration in serum samples), Figure 6C clearly shows that the SPR angle shift decreased significantly (from 0.6 to 0.5 m/pM). The presence of hCG and other interfering chemical components in the serum sample solution caused the sensitivity in the serum samples to be slightly larger than in the buffered standard solutions (1.27 versus 0.6 m/pM) ( Figure 7D ). This was due to the effect of other chemical components in the serum such as proteins, fats, hormones, esters, enzymes, and inorganic substances causing a significant increase in non-specific responses. In addition, improving non-ionic Tween-20 concentrations, increasing ionic sodium dodecyl sulfate (SDS) and increasing the high flow rate could more effectively reduce and damage non-specific interference.
Conclusion
In this study, we demonstrated the potential of a carboxyl-GO-based peptide probe for use in a nonimmune SPR aptasensor. The hCG is a well-established clinical biomarker of pregnancy and certain diseases. This sensor was an effective tool to investigate the mechanism of enhancing the assay efficacy of interactions between peptides and hCG protein with regards to affinity binding for a k a of 17×10 6 M −1 S −1 . These results suggest that adding interfering proteins BSA and HSA did not have a significant effect on the interactions between hCG and peptides. The carboxyl-GObased chip exhibited high charge-transfer properties, indicating that carboxyl-GO can improve electron flux and accelerate electron shuttle between the Au electrode substrate and the electrolyte. In standard solutions with different concentrations of hCG, the carboxyl-GO-based SPR aptasensor presented a response to hCG in the concentration range of 2-100 pM, with a correlation coefficient of 0.981. In clinical serum samples of hCG protein, the detection limit was below 1.15 pM (0.575 mIU/mL), well below the normal physiological level of hCG serum test in ELISA (0.5 ng/mL). The experimental results showed that the increased peptide immobilization can enhance the detection sensitivity. In the future, we believe that carboxyl-GO-based SPR aptasensors can be useful for the early clinical diagnosis of gynecological diseases and cancers, and that the potential clinical applications will benefit an ever increasing number of people and reduce the fatal threat of disease.
